| Title | Updated Results of Pivotal Phase 2 Trials of Olverembatinib (HQP1351) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL1 (T315I)-Mutated Chronic- and Accelerated-Phase Chronic Myeloid Leukemia (CML-CP and CML-AP) |
| Authors | Qian, Jiang Shi, Dayu Li, Zongru Hou, Yue Hu, Yu Li, Weiming Liu, Xiaoli Xu, Na Song, Yongping Zhang, Gongli Meng, Li Hong, Zhenya Liu, Bingcheng Li, Yan Chen, Suning Xue, Mengxing Zhu, Huanling Li, He Du, Xin Lou, Jin Zhang, Xiaohan Liang, Yang Dai, Yujun Chen, Zi Niu, Qian Men, Lichuang Yang, Dajun Zhai, Yifan Huang, Xiaojun |
| Affiliation | Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China Natl Clin Res Ctr Blood Dis, Inst Hematol, Tianjin, Peoples R China Natl Clin Res Ctr Blood Dis, Blood Dis Hosp, Tianjin, Peoples R China Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou, Peoples R China Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Div Hematol, Shenzhen, Peoples R China Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou, Peoples R China Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Shanghai, Peoples R China Guangzhou Healthquest Pharma Co Ltd, Guangzhou, Peoples R China Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China Ascentage Pharma Grp Inc, Rockville, MD USA Chinese Acad Med Sci, Key Tech Diag & Treatments Hematol Malignancies, Res Unit, 2019RU029, Beijing, Peoples R China |
| Issue Date | 23-Nov-2021 |
| Publisher | BLOOD |
| URI | http://hdl.handle.net/20.500.11897/652356 |
| ISSN | 0006-4971 |
| DOI | 10.1182/blood-2021-153937 |
| Indexed | SCI(E) |
| Appears in Collections: | 人民医院 |
